Inlyta Medication Information

If you have renal cell carcinoma (kidney cancer) that has spread to other areas of the body, your healthcare provider may prescribe Inlyta® (axitinib) to help slow down the progression of the cancer. This medicine is specifically approved for use in adults who have not adequately responded to at least one other type of kidney cancer medication.
 
Inlyta comes as a tablet that is taken by mouth twice a day, with 12 hours between each dose. Your specific dosage will depend on how well you tolerate it, whether you are taking other drugs, and other factors.
 
Before starting treatment with Inlyta, make sure to discuss the medication's safety information with your healthcare provider. Although this drug can be effective for many people, it is not the best option for everyone. If you have certain allergies, thyroid problems, or a history of bleeding problems, Inlyta may not be the most appropriate chemotherapy medicine for you.
 
(Click Inlyta for more information on this medication, including how it works to slow down the progression of kidney cancer, details on safety and effectiveness, and more.)
 

Inlyta Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.